Ceramides are bioactive lipid metabolites that increase in metabolic tissues during obesity and induce cellular dysfunction via inhibition of the insulin, apoptotic and mitochondrial energy utilisation pathways (14, 15). The gene discussed is INS; the disease is obesity disorder.